Dueling for Duals: Why the Poorest Medicare Recipients Should be Pharma's Top Priority in 2006

The transfer of the poorest Medicare recipients to Part D means big changes in a critical submarket for pharma. If all goes well, it should pay off in a de facto price increase for some of the biggest industry blockbusters.